Kuros Biosciences AG (SWX: KURN)

Market Cap	802.18M
Revenue (ttm)	52.54M
Net Income (ttm)	-8.89M
Shares Out	37.57M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	158,825
Open	21.85
Previous Close	22.15
Day's Range	21.25 - 22.15
52-Week Range	3.49 - 32.00
Beta	0.87
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 80
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2023, Kuros Biosciences AG's revenue was 33.56 million, an increase of 86.61% compared to the previous year's 17.99 million. Losses were -13.73 million, -5.95% less than in 2022.